BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 19266260)

  • 41. Intravenous cyclophosphamide pulse therapy for the treatment of lung disease associated with scleroderma.
    Davas EM; Peppas C; Maragou M; Alvanou E; Hondros D; Dantis PC
    Clin Rheumatol; 1999; 18(6):455-61. PubMed ID: 10638770
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pulmonary Vascular Morphology Associated With Gas Exchange in Systemic Sclerosis Without Lung Fibrosis.
    Zhai Z; Staring M; Ninaber MK; Vries-Bouwstra JK; Schouffoer AA; Kroft LJ; Stolk J; Stoel BC
    J Thorac Imaging; 2019 Nov; 34(6):373-379. PubMed ID: 30817504
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Predictors of pulmonary hypertension on high-resolution computed tomography of the chest in systemic sclerosis: a retrospective analysis.
    Pandey AK; Wilcox P; Mayo JR; Sin D; Moss R; Ellis J; Brown J; Leipsic J
    Can Assoc Radiol J; 2010 Dec; 61(5):291-6. PubMed ID: 20382500
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.
    Antoniou KM; Margaritopoulos GA; Goh NS; Karagiannis K; Desai SR; Nicholson AG; Siafakas NM; Coghlan JG; Denton CP; Hansell DM; Wells AU
    Arthritis Rheumatol; 2016 Apr; 68(4):1004-12. PubMed ID: 26636545
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Pulmonary involvement in sclerodermia].
    Paone G; Di Michele L; Mattia P; Tonnarini R; Lucifora V; Fiorucci F
    Minerva Med; 1994 Jun; 85(6):293-300. PubMed ID: 8084431
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Brief Report: Pulmonary Function Tests: High Rate of False-Negative Results in the Early Detection and Screening of Scleroderma-Related Interstitial Lung Disease.
    Suliman YA; Dobrota R; Huscher D; Nguyen-Kim TD; Maurer B; Jordan S; Speich R; Frauenfelder T; Distler O
    Arthritis Rheumatol; 2015 Dec; 67(12):3256-61. PubMed ID: 26316389
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surfactant protein D and KL-6 as serum biomarkers of interstitial lung disease in patients with scleroderma.
    Hant FN; Ludwicka-Bradley A; Wang HJ; Li N; Elashoff R; Tashkin DP; Silver RM;
    J Rheumatol; 2009 Apr; 36(4):773-80. PubMed ID: 19286849
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bronchiectasis in systemic sclerosis. A study using high resolution computed tomography.
    Andonopoulos AP; Yarmenitis S; Georgiou P; Bounas A; Vlahanastasi C
    Clin Exp Rheumatol; 2001; 19(2):187-90. PubMed ID: 11326482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cardiac Intravoxel Incoherent Motion Diffusion-Weighted Magnetic Resonance Imaging With T1 Mapping to Assess Myocardial Perfusion and Fibrosis in Systemic Sclerosis: Association With Cardiac Events From a Prospective Cohort Study.
    Terrier B; Dechartres A; Gouya H; Ben Arfi M; Bérézne A; Régent A; Dunogué B; London J; Cohen P; Guillevin L; Le Jeunne C; Legmann P; Vignaux O; Mouthon L
    Arthritis Rheumatol; 2020 Sep; 72(9):1571-1580. PubMed ID: 32379399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pleural irregularity, a new ultrasound sign for the study of interstitial lung disease in systemic sclerosis and antisynthetase syndrome.
    Pinal-Fernandez I; Pallisa-Nuñez E; Selva-O'Callaghan A; Castella-Fierro E; Simeon-Aznar CP; Fonollosa-Pla V; Vilardell-Tarres M
    Clin Exp Rheumatol; 2015; 33(4 Suppl 91):S136-41. PubMed ID: 26315813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Idiopathic interstitial pneumonitis presenting with Wells grade III. Can imaging methods help predict further progression of disease?].
    Fasano L; Zompatori M; Monetti N; Battista G; Pacilli AM; Scioscio V Di; Sciascia N
    Radiol Med; 1999 Oct; 98(4):268-74. PubMed ID: 10615366
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Lung involvement in systemic sclerosis: role of high resolution computed tomography and its relationship with other pulmonary and clinico-serological features.
    Colaci M; Sebastiani M; Manfredi A; Giuggioli D; Cassone G; Manzini CU; Ghizzoni C; Cerri S; Ferri C
    J Biol Regul Homeost Agents; 2014; 28(3):481-8. PubMed ID: 25316135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term N-acetylcysteine therapy in systemic sclerosis interstitial lung disease: a retrospective study.
    Rosato E; Rossi C; Molinaro I; Giovannetti A; Pisarri S; Salsano F
    Int J Immunopathol Pharmacol; 2011; 24(3):727-33. PubMed ID: 21978705
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assessments of pulmonary involvement in patients with systemic sclerosis.
    Gohari Moghadam K; Gharibdoost F; Parastandechehr G; Salehian P
    Arch Iran Med; 2011 Jan; 14(1):22-6. PubMed ID: 21194257
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship Between Esophageal Abnormalities on Fluoroscopic Esophagram and Pulmonary Function Testing in Juvenile Systemic Sclerosis.
    Ambartsumyan L; Zheng HB; Iyer RS; Soares J; Henstorf G; Stevens AM
    Arthritis Care Res (Hoboken); 2019 Nov; 71(11):1444-1449. PubMed ID: 30295423
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Subclinical pulmonary abnormalities in childhood-onset systemic lupus erythematosus patients.
    Veiga CS; Coutinho DS; Nakaie CM; Campos LM; Suzuki L; Cunha MT; Leone C; Silva CA; Rodrigues JC
    Lupus; 2016 May; 25(6):645-51. PubMed ID: 26849883
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Assessment of interstitial lung disease in systemic sclerosis using the quantitative CT algorithm CALIPER.
    Ferrazza AM; Gigante A; Gasperini ML; Ammendola RM; Paone G; Carbone I; Rosato E
    Clin Rheumatol; 2020 May; 39(5):1537-1542. PubMed ID: 31940114
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term efficacy of B cell depletion therapy on lung and skin involvement in diffuse systemic sclerosis.
    Bosello SL; De Luca G; Rucco M; Berardi G; Falcione M; Danza FM; Pirronti T; Ferraccioli G
    Semin Arthritis Rheum; 2015 Feb; 44(4):428-36. PubMed ID: 25300701
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pericardial abnormalities predict the presence of echocardiographically defined pulmonary arterial hypertension in systemic sclerosis-related interstitial lung disease.
    Fischer A; Misumi S; Curran-Everett D; Meehan RT; Ulrich SK; Swigris JJ; Frankel SK; Cosgrove GP; Lynch DA; Brown KK
    Chest; 2007 Apr; 131(4):988-92. PubMed ID: 17426200
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical algorithms for the diagnosis and prognosis of interstitial lung disease in systemic sclerosis.
    Hax V; Bredemeier M; Didonet Moro AL; Pavan TR; Vieira MV; Pitrez EH; da Silva Chakr RM; Xavier RM
    Semin Arthritis Rheum; 2017 Oct; 47(2):228-234. PubMed ID: 28454677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.